slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 43,381-43,410
Pages 10,126
Rows per page 30
Component
43,381-43,410 of 303,780
01
Mainz Biomed NV | Investor Presentation Deck | 27 slidesMainz Biomed NV | Investor Presentation Deck | 27 slides · Mainz Biomed
Pitch deck Investor relations 2 hits
04
The slide uses hub-and-spoke diagrams to visually contrast decentralized vs centralized networks.Mainz Biomed NV | Investor Presentation Deck | 27 slides · Mainz Biomed
Pitch deck Investor relations 2 hits
07
The slide outlines the technical workflow from sample collection to patient report generation.Mainz Biomed NV | Investor Presentation Deck | 27 slides · Mainz Biomed
Pitch deck Investor relations 2 hits
14
The slide features a thumbnail of a scientific poster presentation.Mainz Biomed NV | Investor Presentation Deck | 27 slides · Mainz Biomed
Pitch deck Investor relations 2 hits
15
The slide outlines a multi-step diagnostic process involving FIT analysis, automated extraction, qPCR, and AI/ML analysis.Mainz Biomed NV | Investor Presentation Deck | 27 slides · Mainz Biomed
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done2 hits
22
The slide uses a grid layout to display 9 team members with headshots, names, titles, and company logos.Mainz Biomed NV | Investor Presentation Deck | 27 slides · Mainz Biomed
Pitch deck Investor relations 2 hits
15
The slide features a thumbnail of a scientific poster presentation.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 2 hits
16
The slide outlines a multi-step diagnostic process involving FIT analysis and proprietary DNA/mRNA extraction.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 2 hits
17
The slide provides clinical trial data breakdown for a diagnostic product.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 2 hits
23
The slide uses a grid layout to display headshots, names, titles, and company logos for 9 executives.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 2 hits
06
The chart compares 2022 and 2023 quarterly container volumes.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · Financials2 hits
07
The chart shows a year-over-year comparison of container volume by quarter, with a specific note on the discontinuation of the CCX service.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · Financials2 hits
08
The chart shows quarterly container volume (FEU) for 2022 and 2023. The 1.9% decrease refers to the 3Q23 vs 3Q22 comparison.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · Financials2 hits
10
The chart shows a year-over-year comparison of quarterly operating income, with Q3 2023 highlighted as an estimate.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · Financials2 hits
06
The chart shows a year-over-year decline in container volume for Q3, attributed to the discontinuation of the CCX service.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction2 hits
13
The chart illustrates the reconciliation of cash flow from operations to the net change in cash.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · SatisfactionLoop · So What Cascade2 hits
17
Matson | Results Presentation Deck | 18 slidesMatson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · Action2 hits
07
The slide presents two line charts: one comparing BGM vs Invasive CGM, and one showing raw sugarBEAT data.Nemaura Medical | Investor Presentation Deck | 19 slides · Nemaura Medical
Pitch deck Investor relations Beat · Traction2 hits
15
The slide uses a numbered list format to present two distinct product expansion paths.Nemaura Medical | Investor Presentation Deck | 19 slides · Nemaura Medical
Pitch deck Investor relations 2 hits
16
The slide uses a numbered list format to present future product roadmap items.Nemaura Medical | Investor Presentation Deck | 19 slides · Nemaura Medical
Pitch deck Investor relations 2 hits
10
The chart highlights NYCB's consistently lower non-performing loan ratios compared to the industry benchmark.New York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations Beat · KPI OverviewLoop · Zoom In2 hits
11
NYCB is highlighted in gold; peer median is represented by a dashed line.New York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations Beat · KPI OverviewLoop · Zoom In2 hits
12
The chart uses a grouped bar format to contrast two data series over time. Includes a cumulative total box and a footnote regarding specific exclusions.New York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations Beat · KPI OverviewLoop · Zoom In2 hits
01
Nuvalent | Investor Presentation Deck | 52 slidesNuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations 2 hits
04
Slide 4 of a pitch deck.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations 2 hits
05
Includes a grid of headshots for the leadership team and lists for board members and advisors.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations 2 hits
09
The slide uses a list of icons to represent key clinical attributes of the drug candidate.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
10
The table segments patients into kinase inhibitor naïve and those with 1 prior inhibitor, further sub-segmented by mutation type (G2032R vs Non-G2032R).Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Market SizingLoop · Cost Of Inaction2 hits
11
The table uses a green/white color coding to highlight positive attributes of NVL-520 compared to competitors.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
26
Slide 26 of a pitch deck.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction2 hits